Compare NTCT & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTCT | AORT |
|---|---|---|
| Founded | 1984 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1999 | 1996 |
| Metric | NTCT | AORT |
|---|---|---|
| Price | $31.63 | $36.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $31.00 | ★ $48.76 |
| AVG Volume (30 Days) | ★ 502.9K | 315.1K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ 1.06 | 0.21 |
| Revenue | ★ $891,820,000.00 | $298,836,000.00 |
| Revenue This Year | $6.02 | $14.20 |
| Revenue Next Year | $2.55 | $11.17 |
| P/E Ratio | ★ $29.45 | $168.57 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $18.12 | $21.97 |
| 52 Week High | $32.87 | $48.25 |
| Indicator | NTCT | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 46.03 |
| Support Level | $26.62 | $34.60 |
| Resistance Level | N/A | $38.42 |
| Average True Range (ATR) | 0.87 | 1.15 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 62.82 | 50.63 |
NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.